Back to today’s briefing

Story perspectives

WHO Raises DRC Ebola Risk, UK Pledges £20M Vaccine Trials

5/22/2026

50 10 Full Breakdown

Summary

Story summary

The World Health Organization has raised the DRC Ebola outbreak risk to “very high” and says the vaccine could enter clinical trials within two to three months.
Britain has pledged up to £20 million to support frontline health workers, infection control and disease surveillance in the DRC.
Oxford University scientists are testing the ChAdOx1 BDBV viral-vector vaccine in animal trials, using the same platform as the Covid-19 vaccine.

1 of 1

Story summary

The World Health Organization has raised the DRC Ebola outbreak risk to “very high” and says the vaccine could enter clinical trials within two to three months.
Britain has pledged up to £20 million to support frontline health workers, infection control and disease surveillance in the DRC.
Oxford University scientists are testing the ChAdOx1 BDBV viral-vector vaccine in animal trials, using the same platform as the Covid-19 vaccine.